Symbols / MEIP
MEIP Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-05-15 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | $2.78 |
| Price | $3.07 | Change | 10.43% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-07-23 | down | Laidlaw & Co. | Buy → Hold | — |
| 2024-04-12 | main | Stifel | Hold → Hold | $7 |
| 2024-02-14 | main | Stifel | Hold → Hold | $7 |
| 2023-09-27 | main | Stifel | Hold → Hold | $9 |
| 2023-05-23 | main | Brookline Capital | Buy → Buy | $80 |
| 2023-05-12 | main | Stifel | Hold → Hold | $10 |
- MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’ - Business Wire Wed, 10 Sep 2025 07
- MEI Pharma stock soars after announcing $100 million Litecoin treasury strategy - Investing.com Fri, 18 Jul 2025 07
- Why Is MEI Pharma Stock (MEIP) Up 85% Today? - TipRanks Fri, 18 Jul 2025 07
- MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange - Insider Monkey Sun, 20 Jul 2025 07
- LTC Hits Wall Street Stage: MEI Pharma's 'Litecoin Treasury' Surges Over 80% - Binance Mon, 21 Jul 2025 07
- A 100 Million Dollar Investment: MEI Pharma Ventures Into Litecoin - Bitget Sun, 20 Jul 2025 07
- MEI Pharma Announces $100M Placement To Initiate Litecoin Treasury Strategy: Retail Cheers Charlie Lee’s Addition To Company Board - Stocktwits Fri, 18 Jul 2025 16
- MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire ue, 22 Jul 2025 07
- Will MEIP stock benefit from green energy trends - 2025 Key Lessons & Weekly Watchlist for Consistent Profits - mfd.ru Wed, 11 Feb 2026 08
- MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire ue, 05 Aug 2025 07
- 7 Undervalued Biotech Stocks to Buy for Big-Time Returns - Yahoo Finance Mon, 01 Jul 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MEIP
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|